• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.

作者信息

Kartoglu Umit H, Moore Kelly L, Lloyd John S

机构信息

Extensio et Progressio, 1A Chemin du Pre-d'Orsat, 1245 Collonge-Bellerive, Switzerland.

Immunization Action Coalition, Saint-Paul, MN, United States; Vanderbilt School of Medicine, TN, United States.

出版信息

Vaccine. 2020 Jul 22;38(34):5393-5395. doi: 10.1016/j.vaccine.2020.06.056. Epub 2020 Jun 23.

DOI:10.1016/j.vaccine.2020.06.056
PMID:32600910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7309919/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fece/7309919/e75ca6bc7007/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fece/7309919/e75ca6bc7007/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fece/7309919/e75ca6bc7007/gr1_lrg.jpg

相似文献

1
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.潜在的严重急性呼吸综合征冠状病毒2疫苗面临的后勤挑战以及对研究机构、开发者和制造商的呼吁。
Vaccine. 2020 Jul 22;38(34):5393-5395. doi: 10.1016/j.vaccine.2020.06.056. Epub 2020 Jun 23.
2
Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.新兴制造商在 COVID-19 疫苗研究、开发和供应中的参与。
Vaccine. 2020 Jul 22;38(34):5418-5423. doi: 10.1016/j.vaccine.2020.06.022. Epub 2020 Jun 11.
3
COVID-19 vaccines for all?全民接种新冠疫苗？
Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.
4
COVID vaccination logistics: five steps to take now.新冠疫苗接种后勤保障：当下需采取的五个步骤。
Nature. 2020 Nov;587(7833):194-196. doi: 10.1038/d41586-020-03134-2.
5
Global governance for COVID-19 vaccines.新冠疫苗的全球治理
Lancet. 2020 Jun 20;395(10241):1883. doi: 10.1016/S0140-6736(20)31405-7.
6
If a coronavirus vaccine arrives, can the world make enough?如果新冠病毒疫苗问世，全球能够生产出足够的量吗？
Nature. 2020 Apr;580(7805):578-580. doi: 10.1038/d41586-020-01063-8.
7
Coronavirus: global solutions to prevent a pandemic.冠状病毒：预防大流行的全球解决方案。
Nature. 2020 Feb;578(7795):363. doi: 10.1038/d41586-020-00457-y.
8
Intensifying vaccine production.加强疫苗生产。
Bull World Health Organ. 2020 May 1;98(5):302-303. doi: 10.2471/BLT.20.020520.
9
Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!为什么不存在新冠疫苗？制药行业的科学情报和商业模式必须重新审视！
Expert Opin Drug Discov. 2020 Nov;15(11):1233-1235. doi: 10.1080/17460441.2020.1777980. Epub 2020 Jun 16.
10
COVID-19 vaccines: how to ensure Africa has access.新冠疫苗：如何确保非洲能够获得
Nature. 2020 Oct;586(7828):197-199. doi: 10.1038/d41586-020-02774-8.

引用本文的文献

1
The cell-assembled extracellular matrix: A focus on the storage stability and terminal sterilization of this human "bio" material.细胞组装的细胞外基质：关注这种人类“生物”材料的储存稳定性和终端灭菌。
Acta Biomater. 2023 Aug;166:133-146. doi: 10.1016/j.actbio.2023.05.002. Epub 2023 May 5.
2
Blockchain Powered Vaccine Efficacy for Pharma Sector.区块链赋能制药行业疫苗效力。
Comput Math Methods Med. 2022 Sep 10;2022:4862742. doi: 10.1155/2022/4862742. eCollection 2022.
3
A two-stage decision-support approach for improving sustainable last-mile cold chain logistics operations of COVID-19 vaccines.

本文引用的文献

1
Can we contain the COVID-19 outbreak with the same measures as for SARS?我们能否用应对 SARS 的相同措施来控制 COVID-19 疫情？
Lancet Infect Dis. 2020 May;20(5):e102-e107. doi: 10.1016/S1473-3099(20)30129-8. Epub 2020 Mar 5.
一种用于改善新冠疫苗可持续最后一英里冷链物流运作的两阶段决策支持方法。
Ann Oper Res. 2022 Aug 21:1-31. doi: 10.1007/s10479-022-04906-x.
4
Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach.优化 COVID-19 疫苗接种和高接触人群的作用：基于模型的方法。
PLoS One. 2022 Mar 8;17(3):e0262433. doi: 10.1371/journal.pone.0262433. eCollection 2022.
5
Management of COVID-19 vaccines cold chain logistics: a scoping review.新型冠状病毒肺炎疫苗冷链物流管理：一项范围综述
J Pharm Policy Pract. 2022 Mar 2;15(1):16. doi: 10.1186/s40545-022-00411-5.
6
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants.一种能中和新冠病毒变异株的强效源自羊驼的纳米抗体。
iScience. 2022 Mar 18;25(3):103960. doi: 10.1016/j.isci.2022.103960. Epub 2022 Feb 22.
7
Blockchain Enabled Transparent and Anti-Counterfeiting Supply of COVID-19 Vaccine Vials.基于区块链的新冠疫苗瓶透明且防伪供应
Vaccines (Basel). 2021 Oct 25;9(11):1239. doi: 10.3390/vaccines9111239.
8
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks.新型冠状病毒肺炎：新形成的病毒进化枝、病理生理学、治疗策略和当前疫苗接种任务综述。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1165-1200. doi: 10.1016/j.ijbiomac.2021.10.144. Epub 2021 Oct 25.
9
Use of Stability Modeling to Support Accelerated Vaccine Development and Supply.利用稳定性建模支持加速疫苗研发与供应。
Vaccines (Basel). 2021 Sep 30;9(10):1114. doi: 10.3390/vaccines9101114.
10
A simulation-based analysis for effective distribution of COVID-19 vaccines: A case study in Norway.基于模拟的新冠疫苗有效分配分析：以挪威为例
Transp Res Interdiscip Perspect. 2021 Sep;11:100453. doi: 10.1016/j.trip.2021.100453. Epub 2021 Aug 24.